Revance Therapeutics, Inc.

DB:RTI Stock Report

Market Cap: €375.7m

Revance Therapeutics Future Growth

Future criteria checks 5/6

Revance Therapeutics is forecast to grow earnings and revenue by 70.6% and 21.9% per annum respectively while EPS is expected to grow by 72.6% per annum.

Key information

70.6%

Earnings growth rate

72.6%

EPS growth rate

Pharmaceuticals earnings growth21.5%
Revenue growth rate21.9%
Future return on equityn/a
Analyst coverage

Good

Last updated10 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:RTI - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026430-2255269
12/31/2025344-93-35-249
12/31/2024266-156-108-538
9/30/2024257-303-195-191N/A
6/30/2024251-304-209-201N/A
3/31/2024240-325-221-213N/A
12/31/2023234-324-223-217N/A
9/30/2023204-292-210-204N/A
6/30/2023179-337-214-211N/A
3/31/2023153-341-204-202N/A
12/31/2022133-356-197-194N/A
9/30/2022109-274-214-208N/A
6/30/202299-263-210-203N/A
3/31/202290-274-216-208N/A
12/31/202178-281-232-222N/A
9/30/202163-297-247-239N/A
6/30/202147-303-250-242N/A
3/31/202129-292-218-210N/A
12/31/202015-282-183-179N/A
9/30/20204-249-152-150N/A
6/30/20200-209-129-126N/A
3/31/20200-186-141-138N/A
12/31/20190-159-109-106N/A
9/30/20191-155-108-104N/A
6/30/20193-146-103-97N/A
3/31/20194-143-112-105N/A
12/31/20184-143-111-104N/A
9/30/20183-138-107-102N/A
6/30/20181-136N/A-98N/A
3/31/20180-128N/A-85N/A
12/31/20170-121N/A-95N/A
9/30/20170-111N/A-80N/A
6/30/20170-99N/A-73N/A
3/31/20170-97N/A-65N/A
12/31/20160-89N/A-60N/A
9/30/20160-85N/A-63N/A
6/30/20160-86N/A-62N/A
3/31/20160-78N/A-58N/A
12/31/20150-73N/A-56N/A
9/30/20150-66N/A-48N/A
6/30/20150-60N/A-47N/A
3/31/20150-57N/A-47N/A
12/31/20140-63N/A-55N/A
9/30/20141-49N/A-60N/A
6/30/20141-48N/A-54N/A
3/31/20141-38N/A-62N/A
12/31/201310N/A-48N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: RTI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: RTI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: RTI is expected to become profitable in the next 3 years.

Revenue vs Market: RTI's revenue (21.9% per year) is forecast to grow faster than the German market (5.6% per year).

High Growth Revenue: RTI's revenue (21.9% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if RTI's Return on Equity is forecast to be high in 3 years time


Discover growth companies